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Spy vs. spy: selecting the best reporter for
19F NMR competition experiments†
Guilherme Vieira de Castro and Alessio Ciulli *
Systematic characterization of a series of fluorinated VHL ligands,
varying binding aﬃnity and position of the trifluoromethyl group,
qualifies a spy molecule for competitive 19F NMR screening and
reveals guiding principles to develop highly sensitive assays with
low material consumption.
Over the past few years, the application of nuclear magnetic
resonance (NMR) to study small molecule interactions with
biomolecular targets has increased. Both the large number of
methods available and the ability to detect weak interactions
imperceptible to other biophysical techniques make NMR a
valuable resource for pharmaceutical research, from fragment-
based drug discovery (FBDD) to lead optimization campaigns.1
A powerful approach to detect binders across a range of aﬃnities
consists in competition ligand-observed NMR experiments.2
Competitive ligands are detected by monitoring the signals of
a known binder, also referred to as a reporter or spy molecule.
When a competing ligand is present, the spy molecule will be
displaced from its binding site. The increased relative popula-
tion of free vs. bound state of the spy molecule can be detected
by monitoring diﬀerent NMR parameters and is dependent on
the aﬃnity of the competitor.3 If the binding aﬃnity of the spy
molecule is known, the aﬃnity of the competitors can be
estimated from the extent of the displacement.
In this context, the usage of fluorinated compounds as spy
molecules presents yet further advantages. Fluorine atoms are
absent in most common solvents, buﬀer components and
biomolecules, resulting in simpler datasets to analyze when
compared to proton-based methods. Furthermore, the high
chemical shift anisotropy (CSA) of fluorine yields very clear
responses to changes in the chemical environment, making the
binding detection extremely sensitive.4a Despite many
successful applications of 19F NMR competition experiments,5 the
properties required to achieve sensitive spy molecules remain
understudied. To date, spy molecule selection has consisted in
either picking hits from the screening of a fluorinated compound
library, or preparing fluorinated analogues of a known ligand in an
unguided manner.6 Although aspects of spy molecule design have
been discussed, including use of CF or CF3 groups, residence time,
and fluorine local environment,4,6 the majority of these features are
evaluated solely from a theoretical point of view. It thus remains
unclear how much optimization is needed to obtain the best
spy molecule. Here, a series of fluorinated ligands of a well-
characterized ligand–protein binding system were developed and
their potential as spy molecules was evaluated.
The vonHippel Lindau (VHL) E3 ligase was chosen as the target,
because ligand binding to its hydroxyproline (Hyp) recognition site
is deeply characterized.7 Many Hyp containing ligands are available
with crystallographically characterized binding modes and a wide
range of dissociation constants (KD). Moreover, the development of
a 19F NMR competition assay for probing the Hyp site could see
many valuable applications in the development of novel VHL
ligands and VHL-based chemical degraders,8 and distinguishing
Hyp site binders from those interacting with other sites.7,9
For spy molecule design, a trifluoromethyl (CF3) modifica-
tion was preferred over, e.g., fluoromethyl to generate a larger
set of analogues (high availability of CF3 containing starting
materials) and to yield increased signal to background. The
potent binder VH032 (PDB: 4W9H)7c was used as a template in
the design, and five positions were chosen for placing the CF3
modification (Fig. 1). These positions were selected by consider-
ing potential clashes with the protein, truncating left- and right-
hand side groups to modulate the binding aﬃnity. In total
twenty-two compounds were synthesized by adapting previously
described synthetic routes to prepare VHL ligands.7
Due to the large CSA of fluorine and the significant diﬀerences in
the fluorine isotropic chemical shift (dF) between the free and bound
states, the transverse relaxation rate (R2) is a well-established sensitive
parameter to detect ligand binding.4 Therefore, fluorine NMR experi-
ments including a Carr–Purcell–Meiboom–Gill (CPMG) spin-echo
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filter10 before acquisition were employed to monitor ligand binding
to VHL by measuring peak intensity, as changes in other NMR
parameters, such as chemical shift and peak width, were not as
significant. The R2 values of the CF3 peak of each compound in the
absence and in the presence of protein were determined by perform-
ing multiple 19F CPMG experiments varying the CPMG filter (Fig. 2a).
To quantify the shift in R2 upon binding, the R2 contrast (C2)
11 was
determined. Ideally, a good spymolecule should have a large increase
in R2 (fast relaxation) when protein is present, resulting in a large
assay window for the competition experiments (Fig. 2b).
The KD of each compound to VHL was determined by surface
plasmon resonance (SPR) experiments. The KD of the majority of
the compounds could be measured confidently (Table 1), with
the exception of cases where the binding responses were too low
(KD 4 1.5 mM) or the responses were above the theoretical
maximum response (promiscuous or unspecific binders).
A number of trends can be observed. The weakest binders of
the series (1, 5 and 9) were among the spy molecules with the
lowest C2. In this case the concentration of the spy–protein
complex was much lower than KD, so too small a percentage of
the molecules contributed to the signal, resulting in a low C2
value. On the other hand, as expected the tightest binders of the
Fig. 1 Design of a fluorinated spy molecule series. The co-crystal struc-
ture of VHL binder VH032 (PDB: 4W9H) inspired the choice of five
positions (dashed circles) to attach a CF3 group, either on aromatic (series
A and B) or aliphatic (C–E) regions.
Fig. 2 Evaluation of the sensitivity of a spy molecule. (a) Measurement of
the transverse relaxation rate (R2) of the spy molecule in the absence (blue)
and the presence of protein (red). The C2 quantifies the extent of the shift
in R2 in the presence of protein. (b) Upon addition of protein, the
19F CPMG
signal of a good spy molecule (left) is greatly reduced, resulting in a large
window to detect and rank displacers, while for a poor spy molecule
(right), the diﬀerence between the signals is too small.
Table 1 Characterisation of spy molecules by SPR and 19F NMR
Series Compound R1 R2 KD, SPR (mM) C2
a (%)
A
1 41500 4.1  3.1
2 657  49b 6.5  2.2
3 407  5 28.2  2.3
4 4.39  0.12 38.9  2.5
5 41500 2.2  1.8
6 878  98b 37.7  2.6
7 67.1  14.0 62.1  3.0
8 2.99  0.75 17.7  2.2
B
9 41500 0.9  2.7
10 1352  94 b 51.9  2.1
11 110  9 47.9  4.1
12 1.14  0.12 7.6  2.4
13 c 3.2  2.0
14 c 53.9  2.5
15 35.2  7.0 41.3  2.7
16 0.268  0.030 1.3  2.4
C
17 — 645  100b 62.0  2.6
18 — 24.8  3.4 76.0  3.2
D
19 — 145  29 70.1  4.5
20 — 12.4  1.9 48.4  5.6
E
21 — 0.447  0.085 3.7  8.8
22 — 0.0969  0.0068 0.8  8.6
a Conditions: spy molecule at 100 mM in the absence or presence of
protein at 1 mM. b Intermediate-weak binders, KD obtained by fitting
the data with a 1-to-1 binding model as the maximum response (RMAX)
could not be obtained experimentally. c High responses in the SPR
experiments, promiscuous or unspecific binders.
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series (12, 16, 21 and 22) also presented a very low C2. This is
due to their higher residence time in the binding site, not
allowing many molecules to interact with the protein during
the time of the NMR experiment. Notably, despite the high
affinities, the dissociation rates of these compounds were
too high to be determined accurately by SPR, showing that
only remarkably fast binding kinetics can yield a sensitive spy
molecule at low protein concentrations.
By plotting C2 versus pKD (Fig. 3a), two binding aﬃnity limits
where the spy molecule sensitivity decays could be observed,
only molecules of pKD = 3.0–5.5 presented good values of C2. To
understand the effect of the position of the CF3 group, we
plotted C2 versus pKD for ligands within the series A (Fig. 3b)
and B (Fig. 3c). In both cases the data are distributed as a bell-
shaped curve, whereby ideal spy molecules should be weak
enough to possess very fast kinetics, but not too weak, so the
amount of spy–protein complex is sufficiently populated to
allow for detecting overall changes in relaxation. This observa-
tion agrees with the theoretical prediction by Dalvit et al.
varying the residence time of the fluorinated ligand.4b
Interestingly, the best aﬃnity range varied across the two
series, with optimal pKD E 4.4 (KD E 40 mM) for series A and
pKD E 3.4 (KD 400 mM) for series B. This result could
be explained by diﬀerences in association rates (kon) or DdF (bound
and free states) of equivalent compounds between the series,
leading to diﬀerent sensitivities at the same KD. This observation
shows that not only the absolute aﬃnity, but also the chemical
environment surrounding the fluorine atom in the context of the
bound ligand aﬀected the sensitivity of the spymolecules. In further
support of the importance of the fluorine position, 7, 11 and 19
(Fig. 3a, dashed circle) all had similar aﬃnities (pKDE 3.8–4.2) but
different C2 due to varying CF3 attachments.
The most sensitive spy molecules (Table 1, highest C2) were
7, 17, 18 and 19. Although molecule 18 presented the overall
highest sensitivity, molecule 19 was selected for setting the
competition assay. As 19 is seven times weaker than 18, it was
hypothesized that 19 would be more readily displaced by weak
competitor fragments, allowing a wider range of KD detection.
Molecule 19 was also preferred over 17 because its aﬃnity could
be determined more accurately by SPR (ESI,† Fig. S1).
Spy molecule 19 consistently displayed good sensitivity
under diﬀerent conditions. When the concentrations of spy
and protein were simultaneously lowered, a binding response
could still be observed even at the lowest concentrations
(19 at 5 mM, VHL at 125 nM), albeit with lower signal-to-noise
ratio (S/N) and C2, requiring longer experiment times (Fig. 4a).
Most conditions displayed a reasonable C2 (Z40%), allowing
the detection of competitors even with low material consump-
tion and number of scans (4 minutes per sample). In any case,
conditions with C2 as high as possible should be aimed for
whenever possible.
Noticeably, the C2 values were aﬀected to a great extent by the
total amount of protein rather than the total amount of spy
molecule (Fig. 4b). At 1.0 mM of protein the C2 values varied
Fig. 3 Relationship between sensitivity, aﬃnity and position of the fluori-
nated group. (a) Correlation between C2 and the respective pKD of all the
spy molecules where the aﬃnity could be estimated, highlighting the
regions where the sensitivity of the spy molecules decays considerably.
Dashed circles display molecules with similar pKD that possess diﬀerent C2
due to the variation in the fluorine attachment. The same plot was also
made for the aromatic series A (b) and B (c), where the trend of an ideal
intermediate aﬃnity can be observed.
Fig. 4 Binding response can be observed at low concentrations of spy
molecule 19 and protein. (a) Overlay of the 19F CPMG peak (200 ms filter)
of spy molecule 19 in the absence (blue) and presence of protein (red). When
lowering the concentrations of spy molecule and protein, the S/N and C2
values respectively decreased. (b) Measurement of the C2 of spy molecule 19
at diﬀerent concentrations (in triplicates), in the presence of four concentra-
tions of protein. The error progressively increases as the concentration of spy
molecule goes down, due to the increase in noise of the NMR data.
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between 70 and 80% for all the concentrations of spy tested, even
if they were around 1.5–15 times lower than the KD. In this way,
for selecting the most sensitive spy molecule of a series, a single
screening at fixed concentration of protein is adequate to deter-
mine the best compounds to set up the competition assay, even if
affinities vary significantly and sub-KD concentrations are used.
Lastly, the utility and scope of using spy molecule 19 to quantify
binding of competitors across a wide range of aﬃnities was eval-
uated (Fig. 5). Five compounds were titrated against 19 at 50 mM and
VHL at 1.0 mM. In all cases the displacement of the spymolecule was
concentration-dependent and the Ki (inhibition constant) values
were derived from the respective IC50 using a competitive binding
model.12 Themeasured binding aﬃnities compared remarkably well
with the respective values obtained by SPR across 4-log units. The
same experiment was attempted with spy molecules 6 and 11 under
the same conditions, and in these cases, the assay could not
diﬀerentiate the binders as eﬃciently (ESI,† Fig. S2–S4), since this
would require higher protein concentration. Binders of other pockets
present in the VHL E3 ligase previously reported did not displace spy
molecule 19 as expected, showing that the displacement is site-
specific (ESI,† Fig. S5).
In summary, we qualify a broad-scope high-quality spy molecule
for the E3 ligase VHL able to diﬀerentiate a wide range of KD values
with good correlation with orthogonal techniques. This advance will
aid future screening eﬀorts for novel VHL ligands and chemical
degraders. More broadly, this work provides a blueprint for obtain-
ing the most sensitive reporter for a given protein–ligand system,
while minimizing protein and spy molecule consumption, and
argues for exploring chemical space with fluorine at different
positions of a binding ligand, especially in the early stages of
projects where only weak binders might be available. This guidance
will prove useful to many groups in academia and industry that
develop NMR assays for FBDD or hit optimization campaigns.
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